Furthermore, IL-13 immune response was downregulated in that particular group of patients.[22] Similarly, another study demonstrated the effectiveness of subcutaneous injectable immunotherapy in treating the sinus inflammation and pain in 281 allergic rhinitis patients. The gene discussed is IL13; the disease is allergic rhinitis.